Page 1 of Clinical Trials for Drug AT-101, 21 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Completed
Phase II Safety and Efficacy Study of Single-agent AT-101 in Patients With Relapsed or Refractory B-cell Malignancies
Last Updated: June 24, 2011
Condition(s): Follicular Lymphoma; Diffuse Large Cell Lymphoma; Mantle Cell Lymphoma; Small Lymphocytic Lymphoma; Chronic Lymphocytic Leukemia
2
Completed
A Study of Single-Agent AT-101 in Men With Hormone Refractory Prostate Cancer
Last Updated: August 20, 2010
Condition(s): Hormone Refractory Prostate Cancer
3
Active, not recruiting
Gossypol and Androgen Ablation Therapy in Treating Patients With Newly Diagnosed Metastatic Prostate Cancer
Last Updated: February 1, 2011
Condition(s): Prostate Cancer
4
Terminated
Erlotinib and AT-101 in Advanced Non-Small Cell Lung Cancer (NSCLC) Patients With Epidermal Growth Factor Receptor (EGFR) Activating Mutations
Last Updated: November 22, 2011
Condition(s): Lung Cancer
5
Completed
Safety & Efficacy Study of AT-101 in Combination w/ Rituximab in Previously Untreated Grade I-II Follicular Non-Hodgkin's Lymphoma
Last Updated: August 24, 2010
Condition(s): Follicular Lymphoma
6
Recruiting
A Study of AT-101 in Combination With Docetaxel in Squamous Cell Carcinoma Of The Head and Neck
Last Updated: October 17, 2011
Condition(s): Squamous Cell Carcinoma of the Head and Neck (SCCHN)
7
Terminated
Gossypol, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery
Last Updated: May 9, 2011
Condition(s): Lymphoma; Unspecified Adult Solid Tumor, Protocol Specific
8
Completed
Gossypol (AT-101) and Temozolomide With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
Last Updated: May 1, 2012
Condition(s): Brain and Central Nervous System Tumors
9
Terminated
Study of Lenalidomide in Combination With AT-101 for Relapsed or Refractory B-cell Chronic Lymphocytic Leukemia
Last Updated: September 21, 2011
Condition(s): Lymphocytic Leukemia; Chronic B-Cell Leukemia
10
Recruiting
Gossypol, Cisplatin, and Etoposide in Treating Patients With Advanced Solid Tumors or Extensive Stage Small Cell Lung Cancer
Last Updated: August 14, 2010
Condition(s): Lung Cancer; Unspecified Adult Solid Tumor, Protocol Specific
11
Recruiting
Gossypol Acetic Acid in Treating Patients With Recurrent, Metastatic, or Primary Adrenocortical Cancer That Cannot Be Removed By Surgery
Last Updated: April 7, 2011
Condition(s): Adrenocortical Carcinoma
12
Completed
Gossypol in Treating Patients With Recurrent Extensive-Stage Small Cell Lung Cancer
Last Updated: January 28, 2012
Condition(s): Lung Cancer
13
Completed
A Randomized Phase 2 Study of AT-101 in Combination With Docetaxel in Relapsed/Refractory Non-Small Cell Lung Cancer
Last Updated: August 24, 2010
Condition(s): Non-small Cell Lung Cancer
14
Completed
A Study Comparing AT-101 in Combination With Docetaxel and Prednisone Versus Docetaxel and Prednisone in Men With Chemotherapy-Naïve Metastatic Hormone Refractory Prostate Cancer (HRPC)
Last Updated: November 8, 2010
Condition(s): Hormone Refractory Prostate Cancer
15
Completed
Study of AT-101 in Combination With Topotecan in Relapsed/Refractory Small Cell Lung Cancer
Last Updated: August 20, 2010
Condition(s): Small Cell Lung Cancer
16
Completed
Safety and Efficacy Study of AT-101 in Combination With Docetaxel and Prednisone in Men With HRPC
Last Updated: June 27, 2011
Condition(s): Prostate Cancer
17
Completed
Phase 2 Safety and Efficacy Study of AT-101 in Combination With Rituximab in Patients With Chronic Lymphocytic Leukemia
Last Updated: August 12, 2010
Condition(s): Chronic Lymphocytic Leukemia
18
Withdrawn
Tarceva and AT-101 for Patients With Advanced Non-Small Cell Lung Cancer
Last Updated: January 25, 2011
Condition(s): Carcinoma, Non Small Cell Lung
19
Active, not recruiting
An Open-label, Single-center, Phase 1/ 2 Study of Chemoradiotherapy and AT-101 in Patients With Locally Advanced Esophageal or Gastroesophageal Junction Cancer
Last Updated: February 3, 2010
Condition(s): Locally Advanced Esophageal or GE Junction Cancer
20
Active, not recruiting
Gossypol in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme
Last Updated: April 27, 2012
Condition(s): Brain and Central Nervous System Tumors

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=Drug+AT-101

Page 1 of Clinical Trials for Drug AT-101, 21 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About